Masayuki Miuchi

430 total citations
22 papers, 354 citations indexed

About

Masayuki Miuchi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Masayuki Miuchi has authored 22 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Masayuki Miuchi's work include Diabetes Treatment and Management (14 papers), Diabetes Management and Research (14 papers) and Pancreatic function and diabetes (9 papers). Masayuki Miuchi is often cited by papers focused on Diabetes Treatment and Management (14 papers), Diabetes Management and Research (14 papers) and Pancreatic function and diabetes (9 papers). Masayuki Miuchi collaborates with scholars based in Japan and Australia. Masayuki Miuchi's co-authors include Mitsuyoshi Namba, Jun‐ichiro Miyagawa, Tomoyuki Katsuno, Yoshiki Kusunoki, Tomoya Hamaguchi, Toshihiro Matsuo, Fumihiro Ochi, Takashi Ikawa, Takafumi Akagami and Hiroyuki Konya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetologia and Metabolism.

In The Last Decade

Masayuki Miuchi

22 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayuki Miuchi Japan 13 281 137 87 60 48 22 354
Xiaofei Su China 15 395 1.4× 149 1.1× 167 1.9× 111 1.9× 36 0.8× 50 553
Jenna Elizabeth Hunt Denmark 10 205 0.7× 162 1.2× 108 1.2× 44 0.7× 64 1.3× 20 322
Yoshimichi Takeda Japan 11 152 0.5× 84 0.6× 78 0.9× 17 0.3× 39 0.8× 30 301
Prashant Nadkarni United States 6 115 0.4× 87 0.6× 129 1.5× 24 0.4× 53 1.1× 9 372
Melanie Scott United States 15 313 1.1× 252 1.8× 117 1.3× 76 1.3× 133 2.8× 32 521
V. Médeau France 6 217 0.8× 150 1.1× 73 0.8× 42 0.7× 28 0.6× 9 304
Thipaporn Tharavanij Thailand 11 240 0.9× 301 2.2× 89 1.0× 181 3.0× 38 0.8× 31 477
Emma Leighton United Kingdom 2 157 0.6× 125 0.9× 103 1.2× 132 2.2× 67 1.4× 3 338
Yongwen Zhou China 8 125 0.4× 90 0.7× 121 1.4× 95 1.6× 35 0.7× 25 371
Andrew D. Howard United States 6 126 0.4× 97 0.7× 104 1.2× 24 0.4× 48 1.0× 6 274

Countries citing papers authored by Masayuki Miuchi

Since Specialization
Citations

This map shows the geographic impact of Masayuki Miuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Miuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Miuchi more than expected).

Fields of papers citing papers by Masayuki Miuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Miuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Miuchi. The network helps show where Masayuki Miuchi may publish in the future.

Co-authorship network of co-authors of Masayuki Miuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Miuchi. A scholar is included among the top collaborators of Masayuki Miuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Miuchi. Masayuki Miuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kusunoki, Yoshiki, Tomoyuki Katsuno, Toshihiro Matsuo, et al.. (2016). A case of type 1 diabetes mellitus with which localized insulin allergy was markedly alleviated by switching to insulin glulisine. Acta Diabetologica. 53(5). 845–848. 3 indexed citations
2.
Kusunoki, Yoshiki, Tomoyuki Katsuno, Takafumi Akagami, et al.. (2015). Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring. Diabetes Research and Clinical Practice. 108(2). 342–349. 15 indexed citations
3.
Kusunoki, Yoshiki, Tomoyuki Katsuno, Fumihiro Ochi, et al.. (2015). Insulin resistance and β-cell function influence postprandial blood glucose levels in Japanese patients with gestational diabetes mellitus. Gynecological Endocrinology. 31(12). 929–933. 15 indexed citations
4.
5.
Konya, Hiroyuki, Takashi Ikawa, Yoshiki Kusunoki, et al.. (2014). Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients. Therapeutics and Clinical Risk Management. 10. 547–547. 7 indexed citations
6.
Katsuno, Tomoyuki, Fumihiro Ochi, Yoshiki Kusunoki, et al.. (2014). Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes. Endocrine Journal. 61(4). 365–372. 8 indexed citations
7.
Matsuo, Toshihiro, Yoshiki Kusunoki, Tomoyuki Katsuno, et al.. (2014). Response of incretins (GIP and GLP-1) to an oral glucose load in female and male subjects with normal glucose tolerance. Diabetes Research and Clinical Practice. 106(2). e25–e29. 6 indexed citations
8.
Konya, Hiroyuki, et al.. (2013). Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Konya, Hiroyuki, Tomoyuki Katsuno, Masayuki Miuchi, et al.. (2013). Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus. Diabetes Metabolic Syndrome and Obesity. 6. 317–317. 13 indexed citations
10.
Maeda, Aya, Jun‐ichiro Miyagawa, Masayuki Miuchi, et al.. (2013). Effects of the naturally‐occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non‐obese subjects. Journal of Diabetes Investigation. 4(3). 281–286. 38 indexed citations
11.
Kusunoki, Yoshiki, Tomoyuki Katsuno, Takashi Ikawa, et al.. (2013). Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus. Diabetes Therapy. 4(2). 461–472. 24 indexed citations
12.
Namba, Mitsuyoshi, Tomoyuki Katsuno, Yoshiki Kusunoki, et al.. (2012). New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy. Clinical and Experimental Nephrology. 17(1). 10–15. 18 indexed citations
13.
Kitamura, Noriko, Fumihiro Ochi, Yoshiki Kusunoki, et al.. (2012). A Case of Deep Coma with Early Diagnosed Myxedema. Nihon Naika Gakkai Zasshi. 101(4). 1066–1068. 1 indexed citations
14.
Kusunoki, Yoshiki, Tomoyuki Katsuno, Takashi Ikawa, et al.. (2012). Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin. Endocrine Journal. 60(4). 431–439. 23 indexed citations
15.
Katsuno, Tomoyuki, Jun‐ichiro Miyagawa, Masayuki Miuchi, et al.. (2011). Incretin responses to oral glucose load in Japanese non-obese healthy subjects. Diabetes Therapy. 2(1). 20–28. 6 indexed citations
16.
Katsuno, Tomoyuki, Jun‐ichiro Miyagawa, Masayuki Miuchi, et al.. (2011). Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus. Endocrine Journal. 58(10). 869–877. 22 indexed citations
17.
Katsuno, Tomoyuki, Tomoya Hamaguchi, J Miyagawa, et al.. (2010). Asymmetric dimetylarginine (ADMA) could affect on cardiovascular complications in type 2 diabetes, particularly complicated with nephropathy. Endocrine Journal. 57. 378. 1 indexed citations
18.
Konya, Hiroyuki, Yoshikazu Hasegawa, Tomoya Hamaguchi, et al.. (2010). Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus. Metabolism. 59(9). 1294–1299. 17 indexed citations
19.
Konya, Hiroyuki, Masayuki Miuchi, Takehiko Ueyama, et al.. (2009). Pleiotropic Effects of Mitiglinide in Type 2 Diabetes Mellitus. Journal of International Medical Research. 37(6). 1904–1912. 18 indexed citations
20.
Zhang, Jianfa, Kazuya Yamagata, Junji Kozawa, et al.. (2007). Continuous stimulation of human glucagon-like peptide-1 (7–36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. Diabetologia. 50(9). 1900–1909. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofei Su Breakdown of academic impact, for papers by Jenna Elizabeth Hunt Breakdown of academic impact, for papers by Yoshimichi Takeda Breakdown of academic impact, for papers by Prashant Nadkarni Breakdown of academic impact, for papers by Melanie Scott Breakdown of academic impact, for papers by V. Médeau Breakdown of academic impact, for papers by Thipaporn Tharavanij Breakdown of academic impact, for papers by Emma Leighton Breakdown of academic impact, for papers by Yongwen Zhou Breakdown of academic impact, for papers by Andrew D. Howard
Rankless by CCL
2026